Bax degradation by the ubiquitin/proteasome-dependent pathway: Involvement in tumor survival and progression

Cited by papers we hold 4

• The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy · 2025
  No notice
• The Mitochondrial Permeability Transition Pore and Cancer: Molecular Mechanisms Involved in Cell Death · 2014
  No notice
• Role of proteasomes in disease · 2007
  No notice
• Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy · 2005
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.